Guidance on use and implementation of outcomes-based managed entry agreements for rare disease treatments

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Facey, K; Xoxi, E; Kent, E; Junghans, T; Whittal, A; Drummond, M; Nicod, E; Upadhyaya, S

Journal number: 4

Journal publisher: IMPACT HTA

Published year: 2021

DOI identifier: 10.5281/zenodo.5032658